Ifp Advisors, Inc Aurinia Pharmaceuticals Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$4.11 - $8.14 $267 - $529	65 Added 32.5%	265 $2,000
Q2 2022 Sep 06, 2022	BUY	$8.95 - $12.8 $1,789 - $2,560	200 New	200 $1,000
Q2 2022 Aug 12, 2022	SELL	$8.95 - $12.8 $1,789 - $2,560	-200 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$10.05 - $22.48 $2,010 - $4,496	200 New	200 $2,000
Q3 2021 Oct 06, 2021	SELL	$10.93 - $23.55 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$10.0 - $14.52 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$12.3 - $18.73 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$12.94 - $16.05 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	SELL	$13.19 - $16.66 $13,190 - $16,660	-1,000 Closed	0 $0
Q1 2017 Jun 03, 2019	BUY	N/A	1,000	1,000 $7,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.